Summary The COVID-19 pandemic is unlikely to end until there is global roll-out of vaccines that protect against severe disease and preferably drive herd immunity. Regulators in numerous countries have authorised or approved COVID-19 vaccines for human use, with more expected to be licensed in 20

The recent Indonesia visit is an illustration of iDSI’s ongoing commitment to building capacity in developing countries. HITAP visits help national bodies learn how to conduct Health Technology Assessments, strengthening decision-making processes and enabling gains in the quantity and quality of hea

The International Decision Support Initiative (iDSI) celebrated Universal Health Coverage (UHC) day on 12th December 2017 at the Center for Global Development (CGD) in Washington DC. The event was titled ‘Better Decisions, Better Health: Practical Experiences Supporting UHC from around the world”. P

Since 2013, the HITAP International Unit (HIU) has been providing technical support to various developing countries such as Indonesia, Vietnam, Bhutan, and India by sharing the Thai experience in generating and using health technology assessment (HTA) to inform policy decisions. HITAP works in colla

The value of a Quality-Adjusted Life Year (QALY) used to screen medicines for inclusion in the National List of Essential Medicines (NLEM) in 2013 was 160,000 baht per QALY. Any medicines that cost less than this amount is considered to be cost-effective. However, is this figure consistent with publ

What do you think about COVID-19 vaccination certificates for international travel? This survey on COVID-19 vaccination certificates is part of a regional research study from the COVID-19 vaccination policy research and decision-support initiative in Asia (CORESIA). We would like

หลักการและเหตุผล สถานะทางสุขภาพของประชาชนถือเป็นดัชนีชี้วัดที่สำคัญในการพัฒนาประเทศและถือเป็นหน้าที่หลักของรัฐบาลในกา

This is a promising time for the advancement of evidence and use of health technology assessment (HTA) in the Philippines. The HTA unit, STEP (Sentro ng Pagsusuri ng Teknolohiyang ngkalusugan), is currently conducting three studies to support national decision-making: 1) the economic evaluatio

Yot Teerawattananon, Alia Luz* , Songyot Pilasant, Suteenoot Tangsathitkulchai, Sarocha Chootipongchaivat, Nattha Tritasavit, Inthira Yamabhai and Sripen Tantivess Abstract Background: It is very challenging for resource-limited settings to introduce universal health coverage (UHC), particular

Usa Chaikledkaew BSc(Pharm), MA, PhD*,**, Kankamon Kittrongsiri BSc(Pharm)*,** * Social and Administrative Pharmacy Excellence Research (SAPER) Unit, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand ** Health Intervention and Technology Assessment Program, Minis